BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17922924)

  • 1. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia.
    Ishida K; Ito S; Wada N; Deguchi H; Hata T; Hosoda M; Nohno T
    Mol Cancer; 2007 Oct; 6():62. PubMed ID: 17922924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
    Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
    Jiang Y; Wu Y; Wang F
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study.
    Sathish II; Asokan K; C L K; Ramanathan A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):405-410. PubMed ID: 32102518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
    Prgomet Z; Andersson T; Lindberg P
    Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.
    Reyes M; Rojas-Alcayaga G; Maturana A; Aitken JP; Rojas C; Ortega AV
    Med Oral Patol Oral Cir Bucal; 2015 Sep; 20(5):e540-6. PubMed ID: 26241451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation of β-catenin synchronized with loss of E-cadherin in oral epithelial dysplasia with a characteristic two-phase appearance.
    Alvarado CG; Maruyama S; Cheng J; Ida-Yonemochi H; Kobayashi T; Yamazaki M; Takagi R; Saku T
    Histopathology; 2011 Aug; 59(2):283-91. PubMed ID: 21884207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of p-Smad3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta- and gamma-catenin expression in oral dysplasia.
    Lo Muzio L; Lo Russo L; Falaschini S; Ciavarella D; Pentenero M; Arduino P; Favia G; Maiorano E; Rubini C; Pieramici T; Gandolfo S
    Oral Oncol; 2009 Jun; 45(6):501-4. PubMed ID: 18715817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
    Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
    Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
    J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of integrin-beta1 in oral leukoplakia and early invasive carcinoma and its relationship with cell proliferation].
    Shang JW; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Oct; 43(10):608-11. PubMed ID: 19087624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell morphometric analysis in oral submucous fibrosis, leukoplakia and squamous cell carcinoma].
    Gao S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 May; 27(3):145-7, 189. PubMed ID: 1292898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p16 in oral cancer and premalignant lesions.
    Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
    J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
    Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
    Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.